VANGUARD GROUP INC - 31 Dec 2025 SCHEDULE 13G Report for Nektar Therapeutics Common Stock (NKTR)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: Nektar Therapeutics Common Stock
Symbol: NKTR
Shares outstanding: 20,378,750 shares
Disclosed Ownership: 1,027,089 shares
Ownership: 5%
Form type: SCHEDULE 13G
Filing time: 30 Jan 2026, 14:20:16 UTC
Date of event: 31 Dec 2025
Previous filing: 31 Oct 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	5%	1,027,089	0	143,138	Ashley Grim	Head of Global Fund Administration